Consistency of Helicobacter pylori eradication rates of first-line concomitant and sequential therapies in Korea: A nationwide multicenter retrospective study for the last 10 years.
Bong Eun LeeJoon Sung KimByung-Wook KimJie-Hyun KimJin Il KimJun-Won ChungSeong Woo JeonJeong Hoon LeeJi Hyun KimNa Young KimJu Yup LeeSeung Young SeoSeon-Young ParkSung Eun KimMoon Kyung JooHyun Joo SongKi Bae KimChang-Seok BangHyun Jin KimPublished in: Helicobacter (2021)
Concomitant therapy is the best regimen for the first-line H. pylori eradication showing consistently higher eradication rate with an increasing trend for the last 10 years in Korea. Bismuth quadruple therapy should be considered for second-line therapy after eradication failure using non-bismuth quadruple therapy.